NASDAQ$ARAY

Accuray Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Reported financial results for the first quarter of fiscal year 2021.

Accuray reported a solid start to fiscal year 2021 with net revenue of $85.3 million and operating income of $5.5 million. Adjusted EBITDA grew to $9 million, and the ending backlog increased by 21 percent from the previous year.

  • Net revenue reached $85.3 million, with an operating income of $5.5 million.
  • Adjusted EBITDA increased to $9 million from a loss of $1 million in the prior year's first quarter.
  • Gross orders totaled $50.5 million, while the order backlog ended at $597.3 million, a 21% increase year-over-year.
  • The company expects revenue recognition for China Type A systems to begin in the second quarter of fiscal 2021.

Headline financials

Total Revenue

$85.3M

Previous: $89.6M-4.7%
EPS (adj)

$0.00

Previous: -$0.11+104.0%
Gross Orders

$50.5M

Previous: $78.5M-35.6%
Order Backlog

$597M

Previous: $495M+20.7%
Adjusted EBITDA

$9.03M

Previous: -$968K+1033.2%
Capital Expenditures

-$569K

Previous: -$1.27M+55.1%
Free Cash Flow

-$167K

Previous: -$10.6M+98.4%
Net Income

$402K

Previous: -$9.36M+104.3%
Operating Income

$5.47M

Previous: -$4.28M+227.8%
Gross Profit

$35.4M

Previous: $32.9M+7.5%
Cash & Equivalents

$90M

Previous: $80.9M+11.2%
Total Assets

$465M

Previous: $464M+0.2%

Revenue & EPS history

Accuray · Revenue · Quarterly

$85.3M

Q1 2021-4.7%vs Q1 2020
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

Accuray · $85.3M total across 2 segments · Q1 2021

  • Services Revenue
    $54.1M+4.0%
  • Products Revenue
    $31.3M-16.9%

Forward guidance

Due to the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry, Accuray believes it is prudent to refrain from providing financial guidance for fiscal year 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-0.8%

Avg return

30 days after

47%

30 / 64 earnings

Positive

+49.7%

Q4 2024

Best reaction

-39.6%

Q3 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-39.6%-35.4%
Q2 2026-21.1%-27.6%-35.5%
Q1 2026-15.9%-19.3%-31.7%
Q3 2025-12.9%-16.1%-1.3%
Q2 2025+8.0%-8.0%-25.3%
Q1 2025+8.9%+3.1%+4.7%
Q4 2024+49.7%+62.1%+51.0%
Q3 2024-27.7%-16.0%-16.9%
Q2 2024-5.2%-11.9%-3.3%
Q1 2024-0.7%-7.8%-1.1%
Q4 2023-23.2%-23.2%-35.9%
Q3 2023+14.4%+24.9%+31.0%
Q2 2023+14.3%+18.3%+19.4%
Q1 2023+1.5%+4.5%+2.5%
Q4 2022+27.5%+43.5%+15.0%
Q3 2022-10.2%-15.2%-31.4%
Q2 2022-15.9%-11.0%-13.2%
Q1 2022+9.7%+1.9%-9.3%
Q4 2021-3.7%-10.7%-9.2%
Q3 2021-11.1%-14.7%-22.9%
Q2 2021+4.1%-4.3%-3.3%
Q1 2021+2.5%+16.9%+51.4%
Q4 2020-6.6%-10.6%-17.2%
Q3 2020+26.3%+21.1%+10.0%
Q2 2020+13.4%+3.2%-21.2%
Q1 2020-4.8%-11.4%+5.5%
Q4 2019-15.5%-16.1%-9.6%
Q3 2019+1.7%+4.3%-5.5%
Q2 2019+14.2%+15.5%+36.2%
Q1 2019+32.8%+40.5%+20.1%
Q4 2018+11.5%+14.9%+9.2%
Q3 2018-15.3%-8.9%-10.9%
Q2 2018+8.7%+9.7%-1.9%
Q1 2018+3.5%+14.1%+24.7%
Q4 2017+5.1%+5.1%+14.1%
Q3 2017-5.2%-12.5%-13.5%
Q2 2017+1.8%+1.8%-2.7%
Q1 2017-5.7%-7.5%+0.0%
Q4 2016-8.8%-3.1%-0.5%
Q3 2016-7.1%
Q2 2016-12.2%
Q1 2016+6.3%
Q4 2015+10.2%
Q3 2015-22.4%
Q2 2015+6.0%
Q1 2015-15.9%
Q4 2014+2.6%
Q3 2014-8.9%
Q2 2014+19.4%
Q1 2014+11.4%
Q4 2013+5.1%
Q3 2013+12.2%
Q2 2013-12.4%
Q1 2013+0.0%
Q4 2010-2.8%
Q4 2012-9.3%
Q3 2011-9.4%
Q3 2012-9.4%
Q2 2012+16.6%
Q2 2011+16.6%
Q4 2011-3.5%
Q1 2011-3.5%
Q1 2012-3.5%
Q3 2010-0.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro